In December 2025, a baby boy named Hugo came into the world at Queen Charlotte’s and Chelsea Hospital in London. He weighed 6lb 13oz, arrived by planned Caesarean, and by any outward measure looked like any other healthy newborn. What made Hugo different was invisible; he had grown inside a uterus that wasn’t his mother’s, retrieved from a woman who had died, and transplanted into a body that had never had one.
His birth, announced publicly in February 2026, marks the first time a deceased donor uterine transplant has resulted in a live birth in British medical history. It is, by any reasonable measure, one of the most extraordinary things to happen in a UK hospital in recent memory.
Hugo’s mother, Grace Bell, is an IT programme manager in her 30s who was diagnosed at sixteen with MRKH syndrome (a condition where a girl is born without a functional uterus, affecting roughly one in every 5,000 female births). She had ovaries, she had hormones, she had every desire to carry a child. She simply had nowhere to carry one. For years, surrogacy appeared to be her only option.
Then, in 2024, surgeons at the Oxford Transplant Centre performed a seven-hour operation to transplant a uterus from a deceased donor into Grace. The donor’s family had given specific, additional consent for the reproductive organ to be included in the donation (something that sits outside the standard organ donor register and must be requested separately). The same donor’s heart, lungs, and kidneys saved four other lives. Her uterus created a new one.
Twelve months after the transplant, once regular menstruation confirmed the graft was functioning, Grace began IVF using her own eggs and her partner Steve Powell’s sperm. The pregnancy followed. Hugo arrived at 37 weeks, healthy.
His full name (Hugo Richard Norman Powell) is a quiet tribute. The middle name honours Professor Richard Smith, the surgeon who has spent over two decades building toward this moment, beginning with fertility-preserving cancer surgeries in the 1990s and eventually leading the programme that made this birth possible. The UK’s first transplant baby, Amy Isabel Davidson (born in February 2025 from a living donor), was similarly named after her mother’s donor sister and lead surgeon Miss Isabel Quiroga. These children carry their stories in their names.
The deceased donor model carries a meaningful ethical advantage over its living donor counterpart; no healthy person is put at risk. Living donor surgery takes ten to twelve hours and carries a roughly 19% rate of major complications. The deceased donor approach eliminates that entirely, while data from the International Registry for Uterus Transplantation suggests the live birth rate per successful graft is actually slightly higher (around 71% versus 63% for living donors). The trade-off is a higher rate of graft failure upfront, largely due to longer cold ischemia times during transport, but for many health systems the ethical calculus is compelling.
The programme, run under the charity Womb Transplant UK, currently has permission to conduct fifteen operations in total. It is funded entirely by public donations, costing £25,000 to £30,000 per procedure (a figure that sits in uncomfortable contrast with the fact that standard life-saving transplants are simply NHS care). Professor Smith has described Hugo’s birth as “the end of the beginning,” which is both appropriately modest and quietly thrilling.
There are an estimated 15,000 women of reproductive age in the UK living with absolute uterine factor infertility. For them, the arrival of a 6lb 13oz boy named Hugo is not just a news story. It is, potentially, a door opening.
